Clearpoint Historical Income Statement

CLPT Stock

USD 11.67 0.17 1.44%

Historical analysis of Clearpoint Neuro income statement accounts such as Interest Expense of 366.7 K, Selling General Administrative of 7.5 M or Total Revenue of 25.2 M can show how well Clearpoint Neuro performed in making a profits. Evaluating Clearpoint Neuro income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Clearpoint Neuro's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Clearpoint Neuro latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Clearpoint Neuro is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

About Clearpoint Income Statement Analysis

Clearpoint Neuro Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Clearpoint Neuro shareholders. The income statement also shows Clearpoint investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Clearpoint Neuro Income Statement Chart

At this time, Clearpoint Neuro's Net Interest Income is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 1.2 M in 2024, despite the fact that Operating Income is likely to grow to (21.3 M).

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Net Income Applicable To Common Shares

Total Revenue

Total revenue comprises all receipts Clearpoint Neuro generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Clearpoint Neuro minus its cost of goods sold. It is profit before Clearpoint Neuro operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Clearpoint Neuro. It is also known as Clearpoint Neuro overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Clearpoint Neuro income statement and represents the costs associated with goods and services Clearpoint Neuro provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.

Most accounts from Clearpoint Neuro's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Clearpoint Neuro current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.At this time, Clearpoint Neuro's Net Interest Income is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 1.2 M in 2024, despite the fact that Operating Income is likely to grow to (21.3 M).

	2021	2022	2023	2024 (projected)
Interest Expense	973K	81K	386K	366.7K
Depreciation And Amortization	692K	777K	1.5M	1.5M

Interest Expense Depreciation And Amortization

Clearpoint Neuro income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Net Interest Income	Net Income From Continuing Ops	Selling And Marketing Expenses	Reconciled Depreciation	Non Operating Income Net Other
Depreciation And Amortization		-0.45	0.63	0.88	0.83	0.93	-0.9	-0.91	0.89	-0.9	0.89	0.93	-0.9	-0.06	-0.91	-0.07	-0.01	0.86	-0.94	0.84	0.93	-0.84
Interest Expense	-0.45		-0.5	-0.61	-0.53	-0.64	0.62	0.63	-0.54	0.64	-0.68	-0.63	0.53	-0.08	0.53	0.7	-0.27	-0.6	0.53	-0.55	-0.53	0.56
Selling General Administrative	0.63	-0.5		0.55	0.49	0.65	-0.71	-0.75	0.61	-0.75	0.6	0.66	-0.68	0.22	-0.66	-0.12	-0.45	0.59	-0.75	0.75	0.53	-0.7
Total Revenue	0.88	-0.61	0.55		0.98	0.97	-0.86	-0.87	0.9	-0.86	0.97	0.96	-0.88	-0.28	-0.91	-0.38	0.25	0.83	-0.88	0.88	0.91	-0.9
Gross Profit	0.83	-0.53	0.49	0.98		0.93	-0.81	-0.81	0.88	-0.8	0.91	0.93	-0.84	-0.37	-0.88	-0.37	0.24	0.76	-0.83	0.86	0.86	-0.9
Other Operating Expenses	0.93	-0.64	0.65	0.97	0.93		-0.95	-0.96	0.95	-0.95	0.98	1.0	-0.95	-0.14	-0.96	-0.34	0.13	0.9	-0.95	0.9	0.93	-0.93
Operating Income	-0.9	0.62	-0.71	-0.86	-0.81	-0.95		0.99	-0.94	0.99	-0.89	-0.95	0.99	0.14	0.98	0.33	0.03	-0.9	0.97	-0.87	-0.87	0.9
Ebit	-0.91	0.63	-0.75	-0.87	-0.81	-0.96	0.99		-0.94	1.0	-0.91	-0.97	0.97	0.01	0.96	0.3	0.02	-0.92	0.98	-0.88	-0.87	0.92
Research Development	0.89	-0.54	0.61	0.9	0.88	0.95	-0.94	-0.94		-0.94	0.87	0.96	-0.95	-0.17	-0.96	-0.27	0.01	0.84	-0.94	0.87	0.86	-0.94
Ebitda	-0.9	0.64	-0.75	-0.86	-0.8	-0.95	0.99	1.0	-0.94		-0.91	-0.96	0.97	0.01	0.96	0.31	0.02	-0.92	0.98	-0.88	-0.86	0.92
Cost Of Revenue	0.89	-0.68	0.6	0.97	0.91	0.98	-0.89	-0.91	0.87	-0.91		0.96	-0.89	-0.14	-0.9	-0.37	0.24	0.89	-0.9	0.86	0.93	-0.86
Total Operating Expenses	0.93	-0.63	0.66	0.96	0.93	1.0	-0.95	-0.97	0.96	-0.96	0.96		-0.96	-0.14	-0.97	-0.33	0.1	0.89	-0.96	0.9	0.92	-0.94
Income Before Tax	-0.9	0.53	-0.68	-0.88	-0.84	-0.95	0.99	0.97	-0.95	0.97	-0.89	-0.96		0.23	0.99	0.32	0.02	-0.9	0.98	-0.88	-0.87	0.92
Total Other Income Expense Net	-0.06	-0.08	0.22	-0.28	-0.37	-0.14	0.14	0.01	-0.17	0.01	-0.14	-0.14	0.23		0.27	0.37	-0.26	-0.05	0.08	-0.17	-0.12	0.2
Net Income	-0.91	0.53	-0.66	-0.91	-0.88	-0.96	0.98	0.96	-0.96	0.96	-0.9	-0.97	0.99	0.27		0.29	0.0	-0.87	0.97	-0.9	-0.88	0.93
Income Tax Expense	-0.07	0.7	-0.12	-0.38	-0.37	-0.34	0.33	0.3	-0.27	0.31	-0.37	-0.33	0.32	0.37	0.29		-0.49	-0.38	0.25	-0.27	-0.18	0.4
Interest Income	-0.01	-0.27	-0.45	0.25	0.24	0.13	0.03	0.02	0.01	0.02	0.24	0.1	0.02	-0.26	0.0	-0.49		0.17	0.06	0.02	0.13	-0.03
Net Interest Income	0.86	-0.6	0.59	0.83	0.76	0.9	-0.9	-0.92	0.84	-0.92	0.89	0.89	-0.9	-0.05	-0.87	-0.38	0.17		-0.92	0.82	0.88	-0.8
Net Income From Continuing Ops	-0.94	0.53	-0.75	-0.88	-0.83	-0.95	0.97	0.98	-0.94	0.98	-0.9	-0.96	0.98	0.08	0.97	0.25	0.06	-0.92		-0.89	-0.87	0.93
Selling And Marketing Expenses	0.84	-0.55	0.75	0.88	0.86	0.9	-0.87	-0.88	0.87	-0.88	0.86	0.9	-0.88	-0.17	-0.9	-0.27	0.02	0.82	-0.89		0.85	-0.86
Reconciled Depreciation	0.93	-0.53	0.53	0.91	0.86	0.93	-0.87	-0.87	0.86	-0.86	0.93	0.92	-0.87	-0.12	-0.88	-0.18	0.13	0.88	-0.87	0.85		-0.75
Non Operating Income Net Other	-0.84	0.56	-0.7	-0.9	-0.9	-0.93	0.9	0.92	-0.94	0.92	-0.86	-0.94	0.92	0.2	0.93	0.4	-0.03	-0.8	0.93	-0.86	-0.75

Click cells to compare fundamentals

Clearpoint Neuro Account Relationship Matchups

Clearpoint Neuro income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	259.6K	550K	692K	777K	1.5M	1.5M
Interest Expense	955.2K	1.4M	973K	81K	386K	366.7K
Selling General Administrative	4.3M	5.3M	8.8M	9.6M	11.8M	7.5M
Total Revenue	11.2M	12.8M	16.3M	20.6M	24.0M	25.2M
Gross Profit	7.4M	9.1M	11.3M	13.5M	13.6M	14.3M
Other Operating Expenses	15.8M	19.0M	29.7M	36.9M	46.4M	48.7M
Operating Income	(4.6M)	(6.2M)	(13.4M)	(16.3M)	(22.4M)	(21.3M)
Ebit	(4.6M)	(5.3M)	(13.4M)	(16.4M)	(22.4M)	(21.3M)
Research Development	2.9M	4.7M	9.0M	10.9M	11.7M	12.3M
Ebitda	(4.3M)	(4.8M)	(12.7M)	(15.6M)	(21.0M)	(19.9M)
Cost Of Revenue	3.8M	3.7M	5.0M	7.0M	10.3M	10.9M
Total Operating Expenses	12.0M	15.3M	24.7M	29.9M	36.1M	37.9M
Income Before Tax	(5.5M)	(6.8M)	(14.4M)	(16.4M)	(22.1M)	(21.0M)
Total Other Income Expense Net	(946.1K)	(562K)	(1.0M)	(103K)	357K	329.7K
Net Income	(6.5M)	(9.1M)	(15.3M)	(16.5M)	(22.1M)	(21.0M)
Income Tax Expense	964.2K	2.3M	910K	103K	1.3M	1.1M
Interest Income	848.2K	916.1K	955.2K	386K	443.9K	624.8K
Net Income Applicable To Common Shares	(5.5M)	(6.8M)	(14.4M)	(16.4M)	(14.8M)	(14.1M)
Net Interest Income	(955.2K)	(1.4M)	(973K)	(81K)	379K	398.0K
Net Income From Continuing Ops	(5.5M)	(6.8M)	(14.4M)	(16.4M)	(21.9M)	(20.8M)
Selling And Marketing Expenses	4.8M	5.4M	6.9M	9.4M	12.6M	7.3M
Reconciled Depreciation	250.6K	550K	159K	777K	1.2M	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clearpoint Historical Income Statement

About Clearpoint Income Statement Analysis

Clearpoint Neuro Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Net Income Applicable To Common Shares

Clearpoint Neuro income statement Correlations

Clearpoint Neuro Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clearpoint Neuro income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Clearpoint Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Ebit	+ 0.99	Operating Income
Ebitda	+ 0.99	Operating Income
Income Before Tax	+ 0.99	Operating Income
Net Income	+ 0.99	Income Before Tax

Net Income	- 0.97	Total Operating Expenses
Total Operating Expenses	- 0.97	Ebit
Net Income From Continuing Ops	- 0.96	Total Operating Expenses
Income Before Tax	- 0.96	Total Operating Expenses
Total Operating Expenses	- 0.96	Ebitda
Net Income	- 0.96	Research Development